Dear Friends and Students
This is a debatable and interesting context. These are my personal views. Yesterday Govt. approved India's Home-grown Coronavirus Vaccine, called Covaxin, developed by Bharat Biotech! First, I am happy and proud that we are not less than any other world’s leading Corona vaccine providers.
There are a lot of eyebrows frown with this early & emergency approval! Why? What is wrong? Why not promote and encourage our invention! Confidence is the Investment, right? If we discount our own product, who is going to invest in our capability. It is not developed by a startup, who made their first production, right? It is developed by a 24 years old vaccine manufacturer, having a portfolio of 16 vaccines and exporting to more than 123 countries. Bharat Biotech has a track record of clinical trials in 20 countries and involved more than 7,00,000 volunteers (bbc.com). Is it not a sufficient qualification?
Traditionally Indians were a Fuzzy mindset (problem-solving approach-degree of truth can range anywhere between 0 and 1. Our thinking used to be deep-rooted)! If you see our history, we contributed to many ideas but we never converted them to commercialize products and made money. We documented but never patented as our interest was more towards the free distribution of knowledge (e.g. Vedic scriptures, Samhitas, Upanishads, Ayurveda, Yoga, Aranyakas, etc ).
West is having a predicate mindset (logic: statement is either true (1) or false (0))). This is needed for making product decisions/ marketing, ideas converted to product and commercialization. Hence, they are more successful in commercializing ideas and economy-boosting.
Having said that, over a period, the west became a settled mindset due to laws of abundance whereas Indians started adapting a growth mindset as we are driven by laws of scarcity. In the process, we realized that we need to transition from a Fuzzy Mindset to a Predicate mindset. Slowly, Atmanirbhar Bharat is picking up and pushing our entrepreneurs to develop western equal or better products in the market. Please look at Covaxin from that perspective and promote the products by keeping some confidence in our products.
When there is a huge flood and you need to be rescued, we need to believe someone with huge experience in swimming and give our hand. We should not suspect and ask for a resume, else we will be washed out in the flood.
Dear Dr. Krishna Ella
We appreciate your confidence and commitment. We are proud of you. We are proud of a few of your milestones
Bharat Biotech has acquired Chiron Behring from GSK in March 2019 to become the largest rabies shot producer, Bharat Biotech hits the landmark figure of 100 million doses supply of Rotavac (2019), WHO prequalifies TYPBAR-TCV and ROTAVAC vaccines (2018), TYPBAR-TCV demonstrates 87% efficacy in the world’s first Typhoid Human Challenge study carried out at Oxford University (2017), Bharat Biotech becomes the first company in the world to file a global patent for Zika vaccine (2016), Launches HNVAC® – India’s first cell culture-based H1N1 (Human Inactivated Influenza A virus) Swine flu Vaccine (2010).
We wish you many more achievements in your journey.
#IndiaTooInVaccineRace!!
Your well-wisher
Ravi Saripalle
Source Inspiration: https://hbr.org/2008/07/clash-of-the-mindsets-how-indi
No comments:
Post a Comment